Key Market Indicators
Dutch Medical Product Expenditure is forecast to surge to €5.7 billion by 2028, climbing from €4.5 billion in 2023. This represents an annual compound growth rate (CAGR) of 3.6%. Since the turn of the century, Dutch demand for medical products has consistently grown, marking a 6.6% year-on-year increase. In 2023, the Netherlands ranked fifth globally in medical product expenditure, with Spain narrowly surpassing it at €4.5 billion. Leading the rankings were France, Italy, and Spain, which took the second, third, and fourth positions, respectively.
